APDS Disorder Masked Under Asthma And Tuberculosis: A Rare Case Report

Sri Anjali Gorle, Pannala Harsha Reddy, Raef Nizar Ali, Akhila Vala, Shivkumar Vikasbhai Patel, Dr. Srijamya, Dr. Munawar Izhar

Abstract


Background: Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS) is a rare condition that affects the immune system. It is caused by specific genetic mutations that lead to increased activity of PI3Kδ. One of the main features of this syndrome is recurrent infections in the ear, sinuses, upper and lower respiratory tract. Lymphoma and complications from stem cell transplant are the primary factors contributing to mortality in APDS patients, with mortality rates of 47.6% and 15.6% respectively.
Case: The study presents a case of 24-year-old female with medical history of recurring infections and asthma that was diagnosed at the age of 8. At the tender age of 20, her health began to decline as she faced a series of challenging infections started with Aspergillus, followed by Tuberculosis, then COVID-19, and finally Nocardia.

Discussion: An investigation into primary immunodeficiency was carried out. The immunoglobulin levels were found to be within the normal range, ruling out Common Variable Immunodeficiency (CVID). An analysis of immunochemistry data indicated a significant reduction in the proportion and total count of Natural Killer cells. Although the occurrence of Aspergillosis with a secondary Tuberculosis infection is not frequently observed in APDS, it was indeed identified in this specific case.

Conclusion: This case emphasises the challenging issue of persistent occurrence of opportunistic infections such as nocardiosis, coupled with the development of antibiotic resistance due to prolonged usage making the diagnosis and treatment tough.

Keywords


APDS, Immune system, Asthma, Infections

Full Text:

PDF

References


. Singh A, Jindal A, Mathew B, Rawat A, Jindal V. An updated review on activated PI3 kinase delta syndrome (APDS). Gene Dis. 2019;6(3):209-215. doi:10.1016/j.gendis.2019.09.015.

. Cohen JI. Herpesviruses in APDS. Front Immunol. 2018;9:237. doi:10.3389/fimmu.2018.00237.

. Michalovich D, Nejentsev S. Activated PI3 kinase delta syndrome: From genetics to therapy. Front Immunol. 2018;9:369. doi:10.3389/fimmu.2018.00369.

. 4.Jamee, M., Moniri, S., Zaki-Dizaji, M. et al. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review. Clinic Rev Allerg Immunol 59, 323–333 (2020). https://doi.org/10.1007/s12016-019-08738-9

. Qiu, L., Wang, Y., Tang, W. et al. Activated Phosphoinositide 3-Kinase δ Syndrome: a Large Pediatric Cohort from a Single Center in China. J Clin Immunol 42, 837–850 (2022). https://doi.org/10.1007/s10875-022-01218-4




DOI: http://dx.doi.org/10.52155/ijpsat.v46.2.6586

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Srijamya Srijamya

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.